PAK3 Antibody (YA3567)

PAK3 (p21-activated kinase 3) is a Group I serine/threonine kinase that functions downstream of the small GTPases RAC1 and CDC42, linking extracellular signals to cytoskeletal remodeling and neuronal signaling networks^[1][2]. Mechanistically, PAK3 regulates dendritic development, dendritic spine morphogenesis, synapse formation, and synaptic plasticity, thereby contributing to the establishment and maintenance of neuronal connectivity^[1][2][3]. Through its role in actin-dependent structural remodeling, PAK3 participates in neuroplastic processes that are essential for learning, memory, and higher cognitive functions^[1][3]. In disease contexts, genetic alterations of PAK3 are strongly associated with X-linked intellectual disability and broader neurodevelopmental disorders, highlighting the importance of tightly controlled PAK3 signaling during brain development and function^[2][4]. Experimental studies further demonstrate that impaired PAK3 activity can disrupt hippocampal plasticity and cognitive performance, supporting its utility as a mechanistic model for investigating neurodevelopmental pathogenesis^[5]. Compared with the closely related Group I isoforms PAK1 and PAK2, PAK3 exhibits prominent neuronal expression and has been particularly linked to synapse-associated functions, although all three kinases share substantial sequence homology and overlapping regulatory mechanisms^[2]. For experimental applications, PAK3 is commonly studied through genetic perturbation models and by using Group I PAK inhibitors, including pan-PAK compounds such as FRAX597, which enable investigation of PAK-dependent signaling pathways and cytoskeletal regulation in cellular and disease-relevant systems^[6].